Clinical practice guidelines for insomnia disorder

Insomnia disorder is defined as difficulty in falling asleep, maintaining sleep, and early morning awakenings. Common daytime consequences experienced are fatigue, mood instability and impaired concentration. In chronic insomnia these symptoms persist over a period of at least three months. Chronic...

Full description

Bibliographic Details
Main Authors: Lucille Malan, Nokuthula Dlamini
Format: Article
Language:English
Published: AOSIS 2017-07-01
Series:South African Family Practice
Subjects:
Online Access:https://safpj.co.za/index.php/safpj/article/view/4691
id doaj-a5853e92690245eca36be72244bb8ac2
record_format Article
spelling doaj-a5853e92690245eca36be72244bb8ac22020-11-25T03:56:56ZengAOSISSouth African Family Practice2078-61902078-62042017-07-01593455110.4102/safp.v59i3.46913748Clinical practice guidelines for insomnia disorderLucille Malan0Nokuthula Dlamini1Sefako Makgatho Health Sciences UniversitySefako Makgatho Health Sciences UniversityInsomnia disorder is defined as difficulty in falling asleep, maintaining sleep, and early morning awakenings. Common daytime consequences experienced are fatigue, mood instability and impaired concentration. In chronic insomnia these symptoms persist over a period of at least three months. Chronic insomnia can also be a symptom of a variety of disorders. The pathophysiology of insomnia is theorised as a disorder of nocturnal and daytime hyper-arousal as a result of increased somatic, cortical and cognitive activation. The causes of insomnia can be categorized into situational, medical, psychiatric and pharmacologically-induced. To diagnose insomnia, it is required to evaluate the daytime and nocturnal symptoms, as well as psychiatric and medical history. The Diagnostic and Statistical Manual 5 Criteria (DSM-5) also provides guidelines and criteria to be followed when diagnosing insomnia disorder. Goals of treatment for insomnia disorder are to correct the underlying sleep complaint and this, together with insomnia symptoms, their severity and duration, as well as co-morbid disorders will determine the choice of treatment. In the majority of patients, insomnia can be treated without pharmacological therapy and cognitive behavioural therapy is considered first-line therapy for all patients with insomnia. The most common pharmacological insomnia treatments include benzodiazepines and benzodiazepines receptor agonists. To avoid tolerance and dependence, these hypnotics are recommended to be used at the lowest possible dose, intermittently and for the shortest duration possible. A combination of cognitive behavioural therapy and pharmacological treatment options is recommended for chronic insomnia.https://safpj.co.za/index.php/safpj/article/view/4691insomniabenzodiazepinescognitive behavioural therapysleep wake cyclepharmacologic treatment
collection DOAJ
language English
format Article
sources DOAJ
author Lucille Malan
Nokuthula Dlamini
spellingShingle Lucille Malan
Nokuthula Dlamini
Clinical practice guidelines for insomnia disorder
South African Family Practice
insomnia
benzodiazepines
cognitive behavioural therapy
sleep wake cycle
pharmacologic treatment
author_facet Lucille Malan
Nokuthula Dlamini
author_sort Lucille Malan
title Clinical practice guidelines for insomnia disorder
title_short Clinical practice guidelines for insomnia disorder
title_full Clinical practice guidelines for insomnia disorder
title_fullStr Clinical practice guidelines for insomnia disorder
title_full_unstemmed Clinical practice guidelines for insomnia disorder
title_sort clinical practice guidelines for insomnia disorder
publisher AOSIS
series South African Family Practice
issn 2078-6190
2078-6204
publishDate 2017-07-01
description Insomnia disorder is defined as difficulty in falling asleep, maintaining sleep, and early morning awakenings. Common daytime consequences experienced are fatigue, mood instability and impaired concentration. In chronic insomnia these symptoms persist over a period of at least three months. Chronic insomnia can also be a symptom of a variety of disorders. The pathophysiology of insomnia is theorised as a disorder of nocturnal and daytime hyper-arousal as a result of increased somatic, cortical and cognitive activation. The causes of insomnia can be categorized into situational, medical, psychiatric and pharmacologically-induced. To diagnose insomnia, it is required to evaluate the daytime and nocturnal symptoms, as well as psychiatric and medical history. The Diagnostic and Statistical Manual 5 Criteria (DSM-5) also provides guidelines and criteria to be followed when diagnosing insomnia disorder. Goals of treatment for insomnia disorder are to correct the underlying sleep complaint and this, together with insomnia symptoms, their severity and duration, as well as co-morbid disorders will determine the choice of treatment. In the majority of patients, insomnia can be treated without pharmacological therapy and cognitive behavioural therapy is considered first-line therapy for all patients with insomnia. The most common pharmacological insomnia treatments include benzodiazepines and benzodiazepines receptor agonists. To avoid tolerance and dependence, these hypnotics are recommended to be used at the lowest possible dose, intermittently and for the shortest duration possible. A combination of cognitive behavioural therapy and pharmacological treatment options is recommended for chronic insomnia.
topic insomnia
benzodiazepines
cognitive behavioural therapy
sleep wake cycle
pharmacologic treatment
url https://safpj.co.za/index.php/safpj/article/view/4691
work_keys_str_mv AT lucillemalan clinicalpracticeguidelinesforinsomniadisorder
AT nokuthuladlamini clinicalpracticeguidelinesforinsomniadisorder
_version_ 1724462869137850368